Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 7,675

Document Document Title
WO/2018/065387A1
The present invention relates to hamamelitannin analogues, pharmaceutical compositions comprising the same, and combinations thereof with anti-microbial agents such as antibiotics or disinfectants. It in particular relates to the use of ...  
WO/2018/059372A1
The present invention relates to a group of derivatives synthesized based on the ent-kaurane diterpenoid flexicaulin A and the methods to synthesize such diterpenoid derivatives. In particular, the chemical entities of such synthetic dit...  
WO/2018/062729A1
The present invention relates to a pseudo-ceramide compound and a preparation method therefor. According to the present invention, the pseudo-ceramide compound has a molecular structure and a function similar to those of a natural cerami...  
WO/2018/055170A1
The invention relates to a process for preparing cyclic esters by means of a transesterification reaction in the gas phase, comprising the steps of: (i) vaporizing a liquid solution of alpha-hydroxy esters, (ii) passing the ester vapors ...  
WO/2018/051278A2
The present invention relates to a compound of formula (I) based on enamine derivatives and used as organic hole conductors or hole transporting material in an optoelectronic or photoelectrochemical device. The present invention relates ...  
WO/2018/045941A1
A method for synthesizing glycolide, comprising: forming a binary composite catalytic system using a nontoxic cyclic organic guanidine compound and a nontoxic linear organic guanidine compound; and synthesizing high-purity (≥ 99.9%) gl...  
WO/2018/045938A1
A crude cyclic ester purification method. The present invention provides a quick, efficient, and green crude cyclic ester purification method, comprising three procedures of granulation, washing and separation, and drying. Only water is ...  
WO/2018/041935A1
The present invention relates to photoinitiator compounds of the formula (1) wherein X is O, S or a direct bond; Y is O, S or CR9R10; R1, R2, R3, R4, R5, R6, R7 and R8 independently of each other are hydrogen, halogen, C1- C18alkyl, C5-C...  
WO/2018/038463A1
The present invention relates to a novel compound and an organic electroluminescent device comprising same. The compound according to the present invention is used in an organic layer of an organic electroluminescent device, preferably, ...  
WO/2018/038464A1
The present invention relates to a novel compound and an organic electroluminescent device comprising same. The compound according to the present invention is used in an organic layer of an organic electroluminescent device, preferably, ...  
WO/2018/033085A1
Disclosed are a compound using anthrone as a core and applications thereof in an organic electroluminescent component. The compound uses anthrone as a parent core, which is connected to an aromatic heterocyclic group, so that the molecul...  
WO/2018/026545A1
Provided is an integral 3D humic acid-carbon hybrid foam composed of multiple pores and pore walls, wherein pore walls contain single-layer or few-layer humic acid sheets chemically bonded by a carbon material at their edges and have a c...  
WO/2017/220524A1
The present invention relates to a process for synthesizing lactide, comprising the steps of: providing one or more components to at least one reactor, the one or more components comprising lactic acid and a solvent; - converting at leas...  
WO/2017/220522A1
The present invention relates to a process for synthesizing lactide, comprising the steps of: adding thermal energy to at least one of one or more components; providing the one or more components to at least one reactor, the one or more ...  
WO/2017/220521A1
The present invention relates to a process for synthesizing lactide comprising the steps of: providing one or more components to at least one reactor, the one or more components comprising lactic acid; - converting at least part of the l...  
WO/2017/220519A1
The present invention relates to a process for synthesizing lactide, comprising the steps of: - adding thermal energy to at least one solvent; - providing one or more components to at least one reactor, the one or more components compris...  
WO/2017/204086A1
Provided is a method for preparing a cyclic acetal compound represented by general formula (3) below, the method comprising a step in which compound A, represented by general formula (1) below, and compound B, represented by general form...  
WO/2017/202275A1
Disclosed in the present invention are a bromo benzyl ether derivative, a preparation method therefor, and a pharmaceutical composition and uses thereof. Specifically, the present invention relates to a bromo benzyl ether derivative repr...  
WO/2017/202277A1
Provided is a method for preparing 2-hydroxyl-4-(2, 3-disubstituted benzyloxy)-5-substituted benzaldehyde derivative represented by formula (I). The method comprises the following steps: (1), preparing 2-substitution-3-aryl toluene deriv...  
WO/2017/202273A1
Disclosed in the present invention are a benzyl phenyl ether derivative, a preparation method therefor, and a pharmaceutical composition and uses thereof. Specifically, the present invention relates to a benzyl phenyl ether derivative re...  
WO/2017/202276A1
A phenylate derivative, a preparation method therefor, and a pharmaceutical composition and uses thereof. Specifically, the present invention relates to a phenylate derivative represented by formula I, a pharmaceutically-acceptable salt ...  
WO/2017/204319A1
This compound is characterized by being a compound represented by formula (1). In addition, this glucosylceramide synthase inhibitor is characterized by containing a compound represented by formula (1) or a pharmaceutically acceptable sa...  
WO/2017/190714A1
The present invention relates to chemistry, pharmaceutics, and in particular to the production of formulations from derivatives of phenol compounds or polyphenol compounds and from derivatives of phenol compounds or polyphenol compounds ...  
WO/2017/192304A1
The present disclosure is directed to compounds of formula (I): or a pharmaceutically acceptable salt, solvate or solvate of the salt thereof. Compounds of formula (I) are inhibitors of NOX4 and are useful in the treatment of fibrotic di...  
WO/2017/189953A1
Compositions comprising polymers comprising one or more ketal, monothioketal, and/or thioketal bonds are provided, as well as related methods and kits. In some embodiments, a polymer may comprise one or more repeat units comprising one o...  
WO/2017/187859A1
The present invention is a compound represented by formula (1), a liquid crystal composition containing the compound, and a liquid crystal display element including the composition. In the formula: R is a C1-15 alkyl or the like; ring A1...  
WO/2017/182433A1
The present invention relates to novel hydroxamic acid derivatives as inhibitors of meprin β and/or α, pharmaceutical compositions comprising such compounds, methods for treatment or prophylaxis of diseases or conditions, especially su...  
WO/2017/183539A1
[Problem] To provide a compound that can be used on an industrial scale. [Solution] A compound represented by general formula (4) or a base adduct thereof. (In the formula, R3 and R4 independently represent a hydrogen atom or the like.)  
WO/2017/159525A1
This method for producing a diol having a cyclic acetal skeleton comprises an acetalation reaction step for carrying out an acetalation reaction, in the presence of an acid catalyst, between a starting hydroxypivalaldehyde and at least p...  
WO/2017/158404A1
This invention relates to an improved method for preparing alkylenedioxybenzene compounds of Formula I, from the corresponding ortho-dihydroxy aromatic compound of Formula II wherein n is 0, 1, 2 or 3; and R1 and R2 independently represe...  
WO/2017/143622A1
The present invention relates to a method for synthesizing lactide by means of lactic acid catalysis. In the method, a nano-particle aqueous dispersion of zinc oxide is used as a catalyst, and lactide is synthesized by means of catalysis...  
WO/2017/134002A1
The invention relates to a method for producing (meth) acrylic acid esters with isomeric alcohols obtained by reacting glycerine with formaldehyde (hydroxy substituted dioxanes and dioxolanes) in high yield using catalysts based on titan...  
WO/2017/130551A1
This lactide recovery method is characterized in that polylactic acid and a depolymerization catalyst are introduced into an extruder 1 leading to a vent chamber 3 kept under reduced pressure, the polylactic acid and the depolymerization...  
WO/2017/111544A1
The present invention relates to a novel compound and an organic electroluminescent device comprising same. The compound according to the present invention can be used in an organic layer, and more desirably, in a light emitting layer or...  
WO/2017/096559A1
The present invention relates to the production of xylene derivatives from furfural and its derivatives. The invention describes new routes for converting furfural and its derivatives into xylene derivatives including novel intermediates.  
WO/2017/099109A1
The method for collecting lactide according to the present invention uses a vent chamber 3 in which a first screw transport path 11 is extended; utilizes the first screw transport path 11 to introduce a molten resin composition containin...  
WO/2017/089301A1
The present invention relates to a compound according to formula (I) wherein X represents a bond or -(CRaRb)n-, wherein Ra and Rb each independently represents hydrogen, (C1-C4)alkyl or Ra and Rb together with the carbon atom to which th...  
WO/2017/088738A1
The present invention discloses a modified compound of andrographolide, and particularly discloses a compound shown in formula (I) and (II) or a pharmaceutically acceptable salt thereof.  
WO/2017/078927A1
Novel compounds having a formula (I), embodiments of a method of making the same, and of a composition comprising them are disclosed herein. Also disclosed are embodiments of a method of treating or preventing a metabolic disorder in a s...  
WO/2017/077552A1
A process for the preparation of intermediates 9, useful in the synthesis of sofosbuvir, as well as intermediates of formula [12] are disclosed herein.  
WO/2017/068496A1
The present application relates to an improved process for the preparation of Eliglustat or its pharmaceutically acceptable salts thereof. Further relates to isolation of intermediates in the form of solid and their use for preparation o...  
WO/2017/050298A1
The present invention relates to compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof.  
WO/2017/053793A1
Methods and systems for making intermediates in the synthesis of onapristone are provided. Aspects include the photoconversion of onapristone synthesis intermediates using a narrow band frequency light source.  
WO/2017/014013A1
A compound represented by formula (1). For example, R1 represents an alkyl group having 1-15 carbon atoms; MES represents a mesogenic group having at least one ring; Sp1 represents a single bond or an alkylene group having 1-10 carbon at...  
WO/2017/010399A1
Provided are compounds having RORγt inhibitory effects represented by formula (I). Compounds represented by formula (I) (wherein L represents -NR1ACO-, -SO2- or the like, A represents a substituted or unsubstituted aromatic carbocyclic ...  
WO/2016/207711A8
The present invention provides a method for producing modified lignin, novel modified lignin and novel epoxy resin, as well as novel bisphenol compounds, and resin compositions including these novel bisphenol compounds and novel epoxy re...  
WO/2016/208483A1
The present invention provides a compound represented by general formula (I) and also provides a composition containing the compound, a polymer obtained by polymerizing the composition, and a liquid crystal display element. The compound ...  
WO/2016/207711A1
The present invention provides a method for producing modified lignin, novel modified lignin and novel epoxy resin, as well as novel bisphenol compounds, and resin compositions including these novel bisphenol compounds and novel epoxy re...  
WO/2016/198374A1
Substituted aromatic sulfonamides of formula (I) pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a di...  
WO/2016/201214A1
The present invention relates to compounds which have been discovered to be potent ligands (inhibitors) of human GLUT5 (glucose transporter type 5), a facilitative glucose transporter that transports fructose, and their use as ligands as...  

Matches 1 - 50 out of 7,675